BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernandez A, O'Leary C, O'Byrne KJ, Burgess J, Richard DJ, Suraweera A. Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review. Front Mol Biosci 2021;8:685440. [PMID: 34307454 DOI: 10.3389/fmolb.2021.685440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jurkovicova D, Neophytou CM, Gašparović AČ, Gonçalves AC. DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities. IJMS 2022;23:14672. [DOI: 10.3390/ijms232314672] [Reference Citation Analysis]
2 Liu TT, Li CF, Tan KT, Jan YH, Lee PH, Huang CH, Yu SC, Tsao CF, Wang JC, Huang HY. Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. Cancers (Basel) 2022;14:1787. [PMID: 35406559 DOI: 10.3390/cancers14071787] [Reference Citation Analysis]
3 Gupta S, Panda PK, Hashimoto RF, Samal SK, Mishra S, Verma SK, Mishra YK, Ahuja R. Dynamical modeling of miR-34a, miR-449a, and miR-16 reveals numerous DDR signaling pathways regulating senescence, autophagy, and apoptosis in HeLa cells. Sci Rep 2022;12:4911. [PMID: 35318393 DOI: 10.1038/s41598-022-08900-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Helm A, Fournier C, Durante M. Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications. Expert Rev Mol Med 2022;24:e8. [PMID: 35101155 DOI: 10.1017/erm.2022.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fartushok T, Kovalyshyn O, Fedevych Y, Tanchyn I, Zhykovskiy V. Epigenetics is Promising Direction in Modern Science. Chemistry-Didactics-Ecology-Metrology 2021;26:123-35. [DOI: 10.2478/cdem-2021-0010] [Reference Citation Analysis]
6 Wang J, Huo C, Yin J, Tian L, Ma L, Wang D. Hypermethylation of the Promoter of miR-338-5p Mediates Aberrant Expression of ETS-1 and Is Correlated With Disease Severity Of Astrocytoma Patients. Front Oncol 2021;11:773644. [PMID: 34858853 DOI: 10.3389/fonc.2021.773644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]